These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31625766)

  • 1. Development of risk models for major adverse chronic renal outcomes among patients with type 2 diabetes mellitus using insurance claims: a retrospective observational study.
    Wysham CH; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Duh MS; Young JB
    Curr Med Res Opin; 2020 Feb; 36(2):219-227. PubMed ID: 31625766
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
    Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
    Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.
    Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Kitagawa K; Shimizu M; Furuichi K; Wada T
    PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
    BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients.
    Issar T; Arnold R; Kwai NCG; Walker S; Yan A; Borire AA; Poynten AM; Pussell BA; Endre ZH; Kiernan MC; Krishnan AV
    Clin Neurophysiol; 2019 Nov; 130(11):2088-2095. PubMed ID: 31541986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus.
    Ahn KH; Kim SS; Kim WJ; Kim JH; Nam YJ; Park SB; Jeon YK; Kim BH; Kim IJ; Kim YK
    Korean J Intern Med; 2017 Sep; 32(5):875-882. PubMed ID: 28560862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of patients with type 2 diabetes attending a multidisciplinary diabetes kidney disease clinic.
    Low S; Lim SC; Wang J; Yeoh LY; Liu YL; Lim EK; Shao YL; Chui W; Fun S; Chua CL; Subramaniam T; Sum CF
    J Diabetes; 2018 Jul; 10(7):572-580. PubMed ID: 29154443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
    Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
    J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of progressive chronic kidney disease in individuals with early-onset type 2 diabetes: a prospective cohort study.
    Liu JJ; Liu S; Gurung RL; Ang K; Tang WE; Sum CF; Tavintharan S; Lim SC
    Nephrol Dial Transplant; 2020 Jan; 35(1):115-121. PubMed ID: 30007296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus.
    Li MR; Sun ZJ; Chang DY; Yu XJ; Wang SX; Chen M; Zhao MH
    J Diabetes; 2022 Apr; 14(4):291-297. PubMed ID: 35322566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury.
    Penno G; Garofolo M; Del Prato S
    Nutr Metab Cardiovasc Dis; 2016 May; 26(5):361-73. PubMed ID: 27105869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy.
    Zhang J; Wang Y; Li L; Zhang R; Guo R; Li H; Han Q; Teng G; Liu F
    Ren Fail; 2018 Nov; 40(1):243-251. PubMed ID: 29633887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of normoalbuminuria and renal impairment in type 2 diabetes mellitus
.
    Pichaiwong W; Homsuwan W; Leelahavanichkul A
    Clin Nephrol; 2019 Aug; 92(2):73-80. PubMed ID: 31198168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aetiology of chronic kidney disease and risk factors for disease progression in Chinese subjects: A single-centre retrospective study in Beijing.
    Sui Z; Wang J; Cabrera C; Wei J; Wang M; Zuo L
    Nephrology (Carlton); 2020 Sep; 25(9):714-722. PubMed ID: 32180286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of urine Raman spectra differences from patients with diabetes mellitus and renal pathologies.
    Kavuru V; Senger RS; Robertson JL; Choudhury D
    PeerJ; 2023; 11():e14879. PubMed ID: 36874959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the rs5186 polymorphism of the AGTR1 gene with decreased eGFR in patients with type 2 diabetes from Mexico City.
    Figueroa MAC; Lujambio IM; Gutiérrez TA; Hernández MFP; Ramírez EYE; Guzmán DJ; Sánchez MFL; Morales HFG; Samudio HJG; Sánchez FS; Flores MD; Zamarripa CAJ; Mendoza CCC; Hernández MEO; Velázquez CMO; Flores MS; Orozco DVH; Moreno GYC; Cruz M; de Jesús Peralta Romero J
    Nefrologia (Engl Ed); 2023; 43(5):546-561. PubMed ID: 37996337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
    van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H
    Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
    Chen PM; Wada T; Chiang CK
    Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.